MicroRNA miR-146b-5p regulates signal transduction of TGF-beta by repressing SMAD4 in thyroid cancer


Autoria(s): Geraldo, M. V.; Yamashita, A. S.; Kimura, E. T.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

18/09/2013

18/09/2013

2012

Resumo

MicroRNAs (miRNA) are small non-coding RNAs involved in post-transcriptional gene regulation that have crucial roles in several types of tumors, including papillary thyroid carcinoma (PTC). miR-146b-5p is overexpressed in PTCs and is regarded as a relevant diagnostic marker for this type of cancer. A computational search revealed that miR-146b-5p putatively binds to the 3' untranslated region (UTR) of SMAD4, an important member of the transforming growth factor beta (TGF-beta) signaling pathway. The TGF-beta pathway is a negative regulator of thyroid follicular cell growth, and the mechanism by which thyroid cancer cells evade its inhibitory signal remains unclear. We questioned whether the modulation of the TGF-beta pathway by miR-146b-5p can contribute to thyroid tumorigenesis. Luciferase reporter assay confirmed the direct binding of miR-146b-5p on the SMAD4 3'UTR. Specific inhibition of miR-146b-5p with a locked nucleic acid-modified anti-miR-146b oligonucleotide significantly increased SMAD4 levels in the human papillary carcinoma cell lines, TPC-1 and BCPAP. Moreover, suppression of miR-146b-5p increased the cellular response to the TGF-beta anti-proliferative signal, significantly decreasing the proliferation rate. The overexpression of miR-146b-5p in normal rat follicular PCCL3 cells decreased SMAD4 levels and disrupted TGF-beta signal transduction. MiR-146b-5p overexpression in PCCL3 cells also significantly increased cell proliferation in the absence of thyroid-stimulating hormone and conferred resistance to TGF-beta-mediated cell-cycle arrest. Additionally, the activation of thyroid most common oncogenes RET/PTC3 and BRAF in PCCL3 cells upregulated miR-146b-5p expression. Our results confirm the oncogenic role of miR-146b-5p in thyroid follicular cells and contribute to knowledge regarding the modulation of TGF-beta signal transduction by miRNAs in PTCs. Oncogene (2012) 31, 1910-1922; doi:10.1038/onc.2011.381; published online 29 August 2011

Fundaco de Amparo A Pesquisa do Estado de So Paulo (FAPESP)

Fundaco de Amparo A Pesquisa do Estado de So Paulo (FAPESP)

Conselho Nacional de Desenvolvimento CientUfico e Tecnoloegico (CNPq)

Conselho Nacional de Desenvolvimento CientUfico e Tecnoloegico (CNPq)

Identificador

ONCOGENE, LONDON, v. 31, n. 15, supl. 1, Part 6, pp. 1910-1922, APR, 2012

0950-9232

http://www.producao.usp.br/handle/BDPI/33449

10.1038/onc.2011.381

http://dx.doi.org/10.1038/onc.2011.381

Idioma(s)

eng

Publicador

NATURE PUBLISHING GROUP

LONDON

Relação

ONCOGENE

Direitos

restrictedAccess

Copyright NATURE PUBLISHING GROUP

Palavras-Chave #MICRORNA #TGF-BETA #PAPILLARY THYROID CARCINOMA #GROWTH-FACTOR-BETA #TRANSFORMING GROWTH-FACTOR-BETA-1 #TRANSCRIPTIONAL REGULATION #GENE-EXPRESSION #PCCL3 CELLS #ACTIVIN-A #CARCINOMA #DIFFERENTIATION #THYROTROPIN #ACTIVATION #BIOCHEMISTRY & MOLECULAR BIOLOGY #ONCOLOGY #CELL BIOLOGY #GENETICS & HEREDITY
Tipo

article

original article

publishedVersion